Prescription Weight Loss Drugs for All? episode artwork

EPISODE · Jan 24, 2025 · 53 MIN

Prescription Weight Loss Drugs for All?

from Open to Debate · host Open to Debate

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have opened doors for people to lose weight. Should everyone have the option to take it? Those arguing “yes” say obesity needs to be treated using every available tool, especially for people for whom diet, lifestyle changes, and exercise aren’t enough. Those arguing “no” are concerned about its side effects and the risks if people don’t take them as directed. Now we debate: should prescription weight loss drugs be available for all?    Arguing Yes: David Allison, Obesity Researcher; Dean and Distinguished Professor at the Indiana University School of Public Health-Bloomington  Arguing No: Stuart W. Flint, Associate Professor of the Psychology of Obesity at the University of Leeds    Emmy award-winning journalist John Donvan moderates  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Jan 24, 2025

Embed this episode

Ready to play

Prescription Weight Loss Drugs for All?

0:00 53:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Open to Debate?

This episode is 53 minutes long.

When was this Open to Debate episode published?

This episode was published on January 24, 2025.

Can I download this Open to Debate episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!